Integrating Fluorinated Polymer and Manganese-Layered Double Hydroxide Nanoparticles as pH-activated 19 F MRI Agents for Specific and Sensitive Detection of Breast Cancer.
Cheng ZhangLi LiFelicity Y HanXinying YuXiao TanChangkui FuZhi Ping XuAndrew K WhittakerPublished in: Small (Weinheim an der Bergstrasse, Germany) (2019)
19 F magnetic resonance imaging (19 F MRI) agents capable of being activated upon interactions with cancer triggers are attracting increasing attention, although challenges still remain for precise and specific detection of cancer tissues. In this study, a novel hybrid 19 F MRI agent for pH-sensitive detection of breast cancer tissues is reported, a composite system designed by conjugating a perfluoropolyether onto the surface of manganese-incorporated layered double hydroxide (Mn-LDH@PFPE) nanoparticles. The 19 F NMR/MRI signals from aqueous solutions of Mn-LDH@PFPE nanoparticles are quenched at pH 7.4, but "turned on" following a reduction in pH to below 6.5. This is due to partial dissolution of Mn2+ from the Mn-LDH nanoparticles and subsequent reduction in the effect of paramagnetic relaxation. Significantly, in vivo experiments reveal that an intense 19 F MR signal can be detected only in the breast tumor tissue after intravenous injection of Mn-LDH@PFPE nanoparticles due to such a specific activation. Thus pH-activated Mn-LDH@PFPE nanoparticles are a potential "smart" 19 F MRI agent for precise and specific detection of cancer diseases.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- sensitive detection
- loop mediated isothermal amplification
- papillary thyroid
- diffusion weighted imaging
- magnetic resonance
- room temperature
- squamous cell
- quantum dots
- computed tomography
- metal organic framework
- transition metal
- high resolution
- gene expression
- squamous cell carcinoma
- high dose
- walled carbon nanotubes
- lymph node metastasis
- mass spectrometry
- gold nanoparticles
- working memory
- single molecule
- ultrasound guided
- dna methylation